Status:
COMPLETED
Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation
Lead Sponsor:
Emory University
Collaborating Sponsors:
American Family Life Assurance Company (Aflac Inc.)
Conditions:
Pediatric Cancer
Eligibility:
All Genders
3-10 years
Phase:
NA
Brief Summary
Children with cancer undergo many procedures as part of their treatment, and are often hospitalized or have frequent clinic visits, which can be distressing. Using robots or toys may be promising inte...
Detailed Description
Annually in the US, over 12,500 children and adolescents are diagnosed with cancer. Youth with cancer undergo numerous procedures, clinic visits, and hospitalizations as part of their treatment and ar...
Eligibility Criteria
Inclusion
- Children aged 3.00-10.99 years
- All cancer diagnoses
- English or Spanish speaking (parent and child)
Exclusion
- Patients who receive surgery only will be excluded as they will not have follow-up visits at which to complete the questionnaires
- Patients with cognitive or sensory deficits that would impact being able to interact with MSAD and/or complete questionnaires
- Patients who receive chemotherapy entirely inpatient and never have appointments in the outpatient setting
Key Trial Info
Start Date :
September 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04409301
Start Date
September 18 2020
End Date
January 22 2024
Last Update
February 20 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's of Alabama
Birmingham, Alabama, United States, 35233
2
Connecticut Children's Medical Center
Hartford, Connecticut, United States, 06106
3
Comer Children's Hospital
Chicago, Illinois, United States, 60637
4
Children's Hospital New Orleans
New Orleans, Louisiana, United States, 70118